AXALBION THERAPEUTICS LIMITED
Company number 13224059 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£14,297,961
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-02-24
- Employees
- 7 (2025 accounts)
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT
- Postcode
- WA14 2DT
- Capital
- 2 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-05-15
- Next due by
- 2027-05-29
Nature of business (SIC)
- 21100 Manufacture of basic pharmaceutical products
Officers 7 current · 2 resigned
Stephanie Crispin READ
Director
Thomas COURTNEY
Director
MARC-HENRY PEPPO JULES ROCHAT
Director
PETER VITINS
Director
Paul Hartley GLYER
Director
Contact details
- Website
- axalbion.com
Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options.